Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$411M |
| 2 |
Microsoft
MSFT
|
+$309M |
| 3 |
ExxonMobil
XOM
|
+$258M |
| 4 |
Johnson & Johnson
JNJ
|
+$221M |
| 5 |
GE Aerospace
GE
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$25.2M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.83% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OB
2301
DELISTED
Onebeacon Insurance Group Ltd
OB
| $504K | ﹤0.01% |
40,800
+6,400
| +19% | +$81.7K |
|
2302
LivePerson
LPSN
$33.6M
| $502K | ﹤0.01% |
5,927
+1,100
| +23% | +$90.5K |
|
|
ACTA
2303
DELISTED
Actua Corp
ACTA
| $502K | ﹤0.01% |
57,600
+11,700
| +25% | +$105K |
|
|
SEMI
2304
DELISTED
SunEdison Semiconductor Limited
SEMI
| $502K | ﹤0.01% |
79,900
+12,700
| +19% | +$76.1K |
|
|
STRP
2305
DELISTED
Straight Path Communications Inc.
STRP
| $501K | ﹤0.01% |
16,700
+6,700
| +67% | +$167K |
|
|
AAWW
2306
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $501K | ﹤0.01% |
12,200
+1,900
| +18% | +$71.1K |
|
2307
Corcept Therapeutics
CORT
$12.1B
| $500K | ﹤0.01% |
110,500
+19,800
| +22% | +$77.1K |
|
|
KE
2308
Kimball Electronics
KE
$607M
| $500K | ﹤0.01% |
46,400
+8,900
| +24% | +$95.4K |
|
2309
Harmonic Inc
HLIT
$1.24B
| $499K | ﹤0.01% |
157,700
+26,400
| +20% | +$86.4K |
|
|
REGI
2310
DELISTED
Renewable Energy Group, Inc.
REGI
| $498K | ﹤0.01% |
54,500
+9,200
| +20% | +$70.6K |
|
2311
HCI Group
HCI
$2.29B
| $496K | ﹤0.01% |
15,400
+2,800
| +22% | +$91.2K |
|
|
AFAM
2312
DELISTED
Almost Family Inc
AFAM
| $495K | ﹤0.01% |
13,753
+3,100
| +29% | +$116K |
|
|
LJPC
2313
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $493K | ﹤0.01% |
24,400
+4,400
| +22% | +$78.5K |
|
2314
Houlihan Lokey
HLI
$8.77B
| $492K | ﹤0.01% |
20,436
+3,600
| +21% | +$87.4K |
|
|
MWW
2315
DELISTED
Monster Worldwide Inc
MWW
| $492K | ﹤0.01% |
155,700
+26,300
| +20% | +$102K |
|
|
BBG
2316
DELISTED
Bill Barrett Corp
BBG
| $491K | ﹤0.01% |
81,800
+15,200
| +23% | +$60.9K |
|
2317
Park Aerospace
PKE
$815M
| $490K | ﹤0.01% |
31,700
+5,800
| +22% | +$86.4K |
|
2318
Tejon Ranch
TRC
$447M
| $488K | ﹤0.01% |
25,338
+4,841
| +24% | +$89.1K |
|
|
SP
2319
DELISTED
SP Plus Corporation
SP
| $487K | ﹤0.01% |
21,100
+4,800
| +29% | +$111K |
|
|
PGNX
2320
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $487K | ﹤0.01% |
115,700
+21,200
| +22% | +$94.4K |
|
|
TNGO
2321
DELISTED
Tangoe, Inc.
TNGO
| $485K | ﹤0.01% |
63,500
+11,300
| +22% | +$88.6K |
|
2322
Forrester Research
FORR
$225M
| $482K | ﹤0.01% |
14,850
+2,700
| +22% | +$83.2K |
|
|
CAFD
2323
DELISTED
8point3 Energy Partners LP
CAFD
| $482K | ﹤0.01% |
33,900
+12,900
| +61% | +$198K |
|
|
BETR
2324
DELISTED
Amplify Snack Brands, Inc.
BETR
| $480K | ﹤0.01% |
34,594
+14,894
| +76% | +$166K |
|
2325
Atara Biotherapeutics
ATRA
$80.6M
| $479K | ﹤0.01% |
1,044
+208
| +25% | +$93.6K |
|
Similar funds
Swiss National Bank's Q1 2016 Portfolio in Review
As of Q1 2016, Swiss National Bank held 2,649 positions worth $54.5B, up 32% from $41.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Swiss National Bank deployed $13.6B of net new capital in Q1 2016, opening 6 new positions and adding to 2,585 existing holdings. Its largest new stake was Ferrari: 823,472 shares worth $32.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Stellantis, an estimated $25.2M trimmed.
- Swiss National Bank's largest Q1 2016 buy was Ferrari: 823,472 shares worth $32.9M.
- Swiss National Bank added most to Apple in Q1 2016, an estimated $411M increase.
- Swiss National Bank's biggest Q1 2016 reduction was Stellantis, cutting an estimated $25.2M.
- Swiss National Bank fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $58.7M.
- Swiss National Bank's ten largest holdings make up 15% of its $54.5B portfolio in Q1 2016.
- Swiss National Bank opened 6 new positions and closed 38 in Q1 2016.
- Swiss National Bank's portfolio value rose 32% quarter-over-quarter to $54.5B.
Based on Swiss National Bank's 13F filing for Q1 2016, filed 4 May 2016.